Wholesale Biologics and Peptides for Concierge Medicine Practices

White-label supply options vary by product category. For topical aesthetic biologics and certain device categories, white-label labeling under the practice brand is available depending on the supplier and state regulations. For 503A compounded medications, labeling requirements are governed by pharmacy law and must include the preparation name, strength, dispensing pharmacy, prescriber, and patient information. ExaVeyra can advise on which product categories in the catalog support white-label arrangements and what the documentation requirements are during account onboarding.

503A compounding is patient-specific and prescription-based. A licensed 503A pharmacy prepares the compound pursuant to a valid prescription for an identified patient in a strength or dosage form not commercially available. The compound is dispensed directly to the patient or the prescribing practice for that patient. ExaVeyra works with 503A pharmacy partners to help concierge practices understand the compliant procurement pathway, including how to structure the prescribing relationship, what documentation the pharmacy requires, and how lot-specific COA documentation is provided for each dispensed preparation.

State coverage for compounded preparations depends on the pharmacy partner licensing, the specific compound and dosage form, and state board regulations on interstate dispensing. ExaVeyra works with pharmacy partners covering multiple states and reviews current state coverage during NPI-verified account onboarding. For concierge practices with patients in multiple states or with multi-location practice models, our team can review coverage comprehensively before account approval to confirm which compounds are available in each jurisdiction.

Minimum order quantities for concierge medicine practices vary by product category. Topical biologics and devices typically have lower MOQs than compounded pharmaceutical preparations. Peptide and hormone compounds have MOQs set by the compounding pharmacy partner. For practices with low-volume or patient-specific ordering patterns, MOQ flexibility options may be available depending on the compound and pharmacy partner. Apply for NPI-verified wholesale access to receive a current formulary, MOQ schedule, and tiered pricing for your practice model.

ExaVeyra supports HIPAA-conscious procurement workflows. Where patient-specific information is required for 503A compounding orders, intake is handled through secure channels consistent with applicable HIPAA requirements. ExaVeyra does not store patient health information beyond what is required for order processing. Practices remain responsible for their own HIPAA policies, business associate agreements, and clinical recordkeeping. Our team can advise on how the supply chain interaction fits within a standard BAA framework during account onboarding.

Yes. All approved ExaVeyra wholesale partners receive a dedicated account manager. For concierge medicine practices, the account manager coordinates across peptide protocols, hormone optimization supply, IV therapy compounds, and biologic procurement. They maintain familiarity with the practice formulary, state coverage status, pharmacy partner availability, and documentation requirements. Account managers are available by phone and email during business hours with same-business-day response targets for standard inquiries and priority response for urgent order questions.